NCT03312140View on ClinicalTrials.gov

Examination of the Lipid Metabolism of the Liver After Choline Substitution in Cystic Fibrosis

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 6, 2014

Primary Completion Date

April 24, 2016

Study Completion Date

February 8, 2017

Conditions
Cystic Fibrosis Liver Disease
Interventions
DRUG

Choline Chloride

All Listed Sponsors
lead

University Hospital Tuebingen

OTHER

NCT03312140 - Examination of the Lipid Metabolism of the Liver After Choline Substitution in Cystic Fibrosis | Biotech Hunter | Biotech Hunter